The threat of litigation looms as Purdue Pharma returns to settlement talks
OxyContin maker Purdue Pharma is trying to chart the course for a new mass settlement of thousands of lawsuits over the toll of opioids after the U.S. Supreme Court last month rejected its previous deal, which was years in the making. State, local and tribal governments and individual victims want a sense of justice — … Read more
